English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Select site language

Xaluprine (Mercaptopurine Nova Laboratories) (6-mercaptopurine monohydrate) – Conditions or restrictions regarding supply and use - L01BB02

Updated on site: 10-Oct-2017

Medication nameXaluprine (Mercaptopurine Nova Laboratories)
ATC CodeL01BB02
Substance6-mercaptopurine monohydrate
ManufacturerNova Laboratories Ltd

A.MANUFACTURER RESPONSIBLE FOR BATCH RELEASE

Name and address of the manufacturer responsible for batch release

Nova Laboratories Limited

Martin House

Gloucester Crescent

Wigston, Leicester

LE18 4YL

United Kingdom

B.CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE

Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).

C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION

Periodic Safety Update Reports

The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.

D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT

Risk Management Plan (RMP)

Not applicable

Comments

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Help
  • Get it on Google Play
  • About
  • Info on site by:

  • Presented by RXed.eu

  • 27558

    prescription drugs listed